quinacrine has been researched along with chrysoidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosokawa-Muto, J; Kamatari, YO; Kimura, T; Kuwata, K | 1 |
| Doh-ura, K; Karube, Y; Kataoka, Y; Naito, M; Tamura, K; Tsuruo, T | 1 |
2 other study(ies) available for quinacrine and chrysoidine
| Article | Year |
|---|---|
Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells.
Topics: Acetanilides; Animals; Antiparasitic Agents; Benzhydryl Compounds; Inhibitory Concentration 50; Mice; Molecular Structure; Neurons; Prion Diseases; Prions; Protein Folding; Recombinant Proteins; Structure-Activity Relationship | 2011 |
Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.
Topics: Animals; Brain; Cell Membrane Permeability; Chelating Agents; Drug Evaluation, Preclinical; Endothelial Cells; Mice; Models, Biological; p-Aminoazobenzene; Prion Diseases; Prions; Protein Binding; PrPSc Proteins; Quinacrine; Recombinant Proteins; Tumor Cells, Cultured | 2007 |